No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Humans
-
Immunologic Factors / adverse effects
-
Multiple Sclerosis* / complications
-
Multiple Sclerosis, Relapsing-Remitting* / complications
-
Multiple Sclerosis, Relapsing-Remitting* / drug therapy
-
Natalizumab / adverse effects
Substances
-
Natalizumab
-
Immunologic Factors